Emerge Bioscience Pte. Ltd.
1 products tracked · names used in filings: Emerge Bioscience Pte. Ltd.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 24 Jul 2026🇺🇸 FDA approval
FDA approves biosimilar Garzulys (insulin aspart-fsan)
Emerge Bioscience Pte. Ltd.; BLA761497; Biosimilar; pen, vial · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Garzulys insulin aspart-fsan | Approved | 2026-07-24 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.